Iridian Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.21M Hold
249,586
0.77% 32
2025
Q1
$1.95M Buy
249,586
+80,000
+47% +$626K 0.61% 34
2024
Q4
$1.78M Buy
169,586
+1,886
+1% +$19.8K 0.47% 36
2024
Q3
$2.2M Buy
167,700
+50,000
+42% +$656K 0.47% 37
2024
Q2
$1.65M Buy
117,700
+45,675
+63% +$642K 0.37% 38
2024
Q1
$1.22M Buy
72,025
+18,574
+35% +$314K 0.24% 46
2023
Q4
$755K Buy
53,451
+7,865
+17% +$111K 0.14% 45
2023
Q3
$470K Hold
45,586
0.1% 47
2023
Q2
$751K Buy
+45,586
New +$751K 0.07% 43
2022
Q3
Sell
-30,000
Closed -$73K 55
2022
Q2
$73K Buy
+30,000
New +$73K 0.01% 51
2022
Q1
Sell
-22,279
Closed -$180K 49
2021
Q4
$180K Sell
22,279
-36,222
-62% -$293K 0.01% 62
2021
Q3
$573K Sell
58,501
-172,572
-75% -$1.69M 0.02% 64
2021
Q2
$1.56M Sell
231,073
-12,995
-5% -$87.5K 0.03% 58
2021
Q1
$2.21M Sell
244,068
-101,699
-29% -$919K 0.04% 65
2020
Q4
$2.31M Buy
345,767
+186,567
+117% +$1.25M 0.04% 60
2020
Q3
$802K Hold
159,200
0.02% 64
2020
Q2
$1.29M Buy
159,200
+98,600
+163% +$796K 0.03% 58
2020
Q1
$481K Sell
60,600
-249,869
-80% -$1.98M 0.01% 62
2019
Q4
$2.34M Buy
+310,469
New +$2.34M 0.04% 54
2015
Q4
Sell
-26,480
Closed -$432K 68
2015
Q3
$432K Hold
26,480
﹤0.01% 65
2015
Q2
$561K Sell
26,480
-3,580
-12% -$75.8K ﹤0.01% 69
2015
Q1
$540K Sell
30,060
-1,470
-5% -$26.4K ﹤0.01% 46
2014
Q4
$540K Sell
31,530
-26,740
-46% -$458K 0.01% 48
2014
Q3
$834K Sell
58,270
-1,550
-3% -$22.2K 0.01% 48
2014
Q2
$897K Sell
59,820
-43,200
-42% -$648K 0.01% 47
2014
Q1
$1.38M Sell
103,020
-54,310
-35% -$728K 0.02% 44
2013
Q4
$1.27M Buy
157,330
+20,050
+15% +$161K 0.02% 44
2013
Q3
$901K Buy
137,280
+14,110
+11% +$92.6K 0.01% 46
2013
Q2
$756K Buy
+123,170
New +$756K 0.01% 46